JPS4927577B1 - - Google Patents

Info

Publication number
JPS4927577B1
JPS4927577B1 JP45063694A JP6369470A JPS4927577B1 JP S4927577 B1 JPS4927577 B1 JP S4927577B1 JP 45063694 A JP45063694 A JP 45063694A JP 6369470 A JP6369470 A JP 6369470A JP S4927577 B1 JPS4927577 B1 JP S4927577B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP45063694A
Other languages
Japanese (ja)
Inventor
M Hayashi
K Kimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Priority to JP45063694A priority Critical patent/JPS4927577B1/ja
Priority to ES393423A priority patent/ES393423A1/es
Priority to CH1061071A priority patent/CH560177A5/xx
Priority to BE770187A priority patent/BE770187A/xx
Priority to NL7109987A priority patent/NL7109987A/xx
Priority to FR7126563A priority patent/FR2100937B1/fr
Priority to DE19712136136 priority patent/DE2136136A1/de
Priority to HUOO175A priority patent/HU162630B/hu
Priority to SU1685171A priority patent/SU403157A3/ru
Priority to NO2761/71A priority patent/NO132537C/no
Priority to GB3429871A priority patent/GB1362955A/en
Priority to DK359071AA priority patent/DK128530B/da
Priority to AR236920A priority patent/AR193707A1/es
Priority to SE7109398A priority patent/SE377112B/xx
Publication of JPS4927577B1 publication Critical patent/JPS4927577B1/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP45063694A 1970-07-21 1970-07-21 Pending JPS4927577B1 (enExample)

Priority Applications (14)

Application Number Priority Date Filing Date Title
JP45063694A JPS4927577B1 (enExample) 1970-07-21 1970-07-21
ES393423A ES393423A1 (es) 1970-07-21 1971-07-19 Un metodo para preparar ester heptilico de omega-homo pros-taglandina e1.
CH1061071A CH560177A5 (enExample) 1970-07-21 1971-07-19
BE770187A BE770187A (fr) 1970-07-21 1971-07-19 Ester heptylique de l'omega-homo prostaglandine e1 et sa preparation
NL7109987A NL7109987A (enExample) 1970-07-21 1971-07-20
FR7126563A FR2100937B1 (enExample) 1970-07-21 1971-07-20
DE19712136136 DE2136136A1 (de) 1970-07-21 1971-07-20 Omega Homo prostaglandin E tief 1 heptylester
HUOO175A HU162630B (enExample) 1970-07-21 1971-07-20
SU1685171A SU403157A3 (enExample) 1970-07-21 1971-07-20
NO2761/71A NO132537C (enExample) 1970-07-21 1971-07-20
GB3429871A GB1362955A (en) 1970-07-21 1971-07-21 Omega - homo - prostaglandin e1 heptyl ester and production thereof
DK359071AA DK128530B (da) 1970-07-21 1971-07-21 Analogifremgangsmåde til fremstilling af ω-homo-prostaglandin-E1-heptylester.
AR236920A AR193707A1 (es) 1970-07-21 1971-07-21 Metodo para preparar ester heptilico de omega-homo prostaglandina e1
SE7109398A SE377112B (enExample) 1970-07-21 1971-07-21

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP45063694A JPS4927577B1 (enExample) 1970-07-21 1970-07-21

Publications (1)

Publication Number Publication Date
JPS4927577B1 true JPS4927577B1 (enExample) 1974-07-18

Family

ID=13236724

Family Applications (1)

Application Number Title Priority Date Filing Date
JP45063694A Pending JPS4927577B1 (enExample) 1970-07-21 1970-07-21

Country Status (14)

Country Link
JP (1) JPS4927577B1 (enExample)
AR (1) AR193707A1 (enExample)
BE (1) BE770187A (enExample)
CH (1) CH560177A5 (enExample)
DE (1) DE2136136A1 (enExample)
DK (1) DK128530B (enExample)
ES (1) ES393423A1 (enExample)
FR (1) FR2100937B1 (enExample)
GB (1) GB1362955A (enExample)
HU (1) HU162630B (enExample)
NL (1) NL7109987A (enExample)
NO (1) NO132537C (enExample)
SE (1) SE377112B (enExample)
SU (1) SU403157A3 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163108A (en) * 1967-02-16 1979-07-31 Lever Brothers Company Prostaglandins
DE2317019A1 (de) * 1972-04-27 1973-11-08 Upjohn Co Neue 4,5-didehydro-prostaglandine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL32553A0 (en) * 1968-07-29 1969-09-25 Upjohn Co Prostaglandins and analogs thereof

Also Published As

Publication number Publication date
DE2136136A1 (de) 1972-01-27
BE770187A (fr) 1971-12-01
NL7109987A (enExample) 1972-01-25
GB1362955A (en) 1974-08-07
NO132537B (enExample) 1975-08-18
NO132537C (enExample) 1975-11-26
HU162630B (enExample) 1973-03-28
FR2100937A1 (enExample) 1972-03-24
FR2100937B1 (enExample) 1975-08-01
CH560177A5 (enExample) 1975-03-27
AR193707A1 (es) 1973-05-22
SU403157A3 (enExample) 1973-10-19
ES393423A1 (es) 1974-10-01
SE377112B (enExample) 1975-06-23
DK128530B (da) 1974-05-20

Similar Documents

Publication Publication Date Title
ATA96471A (enExample)
AU1146470A (enExample)
AU2044470A (enExample)
AU1473870A (enExample)
AU1326870A (enExample)
AU2130570A (enExample)
AU2085370A (enExample)
AU2017870A (enExample)
AU1833270A (enExample)
AU1716970A (enExample)
AU1517670A (enExample)
AU1591370A (enExample)
AU1064870A (enExample)
AU2144270A (enExample)
AU2131570A (enExample)
AU2130770A (enExample)
AU1247570A (enExample)
AU1328670A (enExample)
AU1083170A (enExample)
AU1343870A (enExample)
AU1235770A (enExample)
AU2119370A (enExample)
AU2115870A (enExample)
AU1581370A (enExample)
AU2112570A (enExample)